Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Net Equity Issued and Repurchased of -$44000.0 for Q1 2026, down 100.09% on a QoQ basis from $48.2 million in Q4 2025, and down 100.02% year-over-year from $241.4 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Net Equity Issued and Repurchased history runs 12 years deep, the most recent figure standing at -$44000.0 for Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 100.02% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.2 million (down 80.05% YoY) and the FY2025 annual result came in at $241.4 million, down 43.77% from the prior year.
- Net Equity Issued and Repurchased was -$44000.0 for Q1 2026 at Arrowhead Pharmaceuticals, down from $48.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $241.4 million in Q1 2025 and bottomed at -$44000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 48.20 Mn |
| Dec 31, 2025 | 48.20 Mn |
| Mar 31, 2025 | 241.39 Mn |
| Mar 31, 2025 | 241.39 Mn |
| Mar 31, 2020 | -21,000.00 |
| Mar 31, 2020 | -21,000.00 |
| Dec 31, 2019 | 250.50 Mn |
| Dec 31, 2019 | 250.50 Mn |
| Jun 30, 2019 | 60.52 Mn |
| Jun 30, 2019 | 60.52 Mn |
| Mar 31, 2019 | 60.52 Mn |
| Mar 31, 2019 | 60.52 Mn |
| Dec 31, 2018 | 60.52 Mn |
| Dec 31, 2018 | 60.52 Mn |
| Jun 30, 2017 | -272,818.00 |
| Jun 30, 2017 | -272,818.00 |
| Mar 31, 2017 | 191,937.00 |
| Mar 31, 2017 | 191,937.00 |